A new tumor entity of the salivary gland, mammary analo gue secretory carcinoma (MASC) has recently been proposed. The entity was first presented by Skálová et al. in 2010 , 1 as a distinctive neoplasm with strong similarities to breast secretory carcinoma including ETS variant gene 6 (ETV6)neurotrophic tyrosine kinase re ceptor, type 3 (NTRK3) translocation. Since their report, a succession of studies has followed to characterize and distinguish MASC from other salivary gland tumors. 15 Histologically, the tumors have been reported to show a micro cystic, papillarycystic, glandular, or solid growth patterns, low grade vesicular nuclei, pale pink granular or vacuolated "bub bly" cytoplasm, and intraluminal or intracellular secretions, fea turing subtypes of acinic cell carcinoma (AciCC). According to recent study results, MASCs also mimic other salivary gland tumors, including adenocarcinoma, not otherwise specified (ANOS), mucoepidermoid carcinoma (MEC), and cystadeno carcinoma (CAC). 3 Clinically, according to Chiosea et al., 5 MASCs have been known to show a male predilection and more preva lence for nonparotid sites but showed no statistically signifi cant outcome difference, compared to AciCCs. Currently, diag nosing MASCs only by histological features without a molecu lar study is difficult, and their immunohistochemical character istics have not been fully investigated. ETV6-NTRK3 fusion gene is expressed in human secretory breast carcinoma. This gene is the product of a t(12;15)(p13;q25) that fuses the dimerization domain of a transcriptional regula tor (ETV6) on chromosome 12 with a mem brane receptor tyro sine kinase (NTRK3) on chromosome 15 and has also been re ported to associate with infant fibrosarcoma, congenital meso blastic nephroma and acute myelogenous leukemia. ETV6 is genetically unstable, thus susceptible to chromosomal rearran gements, and is implicated in leukemia, myelodysplastic syn dromes and sarcomas, fusing with dozens of genes such as ABL1, FGFR3 Background: A new tumor entity of the salivary glands, mammary analogue secretory carcinoma (MASC) with ETV6-NTRK3 translocation, has recently been proposed. MASC was originally diagnosed as adenocarcinoma, not otherwise specified (ANOS), or acinic cell carcinoma (AciCC) by the current World Health Organization classification. We aimed to identify MASC cases by molecular tests, and to characterize their clinical, histological, and immunohistochemical features. Methods: Thirty cases of MASC candidates were selected after review of 196 salivary gland tumors, and subjected to break-apart ETV6 fluorescence in situ hybridization (FISH), and immunohistochemical study for S100 protein, gross cystic disease fluid protein 15, DOG1, estrogen receptor, and progesterone receptor. Results: Valid FISH results were obtained in 23 cases, and 13 positive cases were retrieved. MASCs were histologically varied, and the most frequent features observed in 10 cases were low-grade papillary/cystic/glandular patterns, intraluminal secretory materials, ovoid/wrinkled nuclei, and relatively abundant granular eosinophilic cytoplasms, corresponding to papillary-cystic or follicular types of AciCC. All cases showed diffuse immunopositivity for S100 protein. Three cases developed recurrences, but all patients remained alive. Conclusions: MASC could be a molecularly well-defined salivary gland neoplasm, encompassing some portions of AciCC and ANOS, but its histological spectrum and clinical implication require further investigation.
Key Words: Salivary gland neoplasms; Carcinoma, acinar cell; In situ hybridization, fluorescence; ETV6-NTRK3 fusion protein, human NTRK3 gene rearrangement has been proven in MASCs as in other epithelial, mesenchymal, or hematopoietic tumors. Re cent studies suggested that the inhibition of ETV6-NTRK3 activation could serve as a therapeutic drug for the treatment of patients with this fusion. 6, 7 This entity is very new, and to date, no case has been docu mented in Korea. We aimed to retrospectively identify MASCs using fluorescence in situ hybridization (FISH) for ETV6 rear rangement, and define the histological, clinical, and immuno histochemical characteristics.
MATERIALS AND METHODS
We selected excised salivary gland tumors, excluding biopsy or consultation cases, from the surgical pathology files of the Asan Medical Center from 1990 to 2012. For retrieval of MASC candidates, 196 salivary gland tumors (MEC, n=137; AciCC, n=43; ANOS, n=11; CAC, n=2; other unusual salivary gland neoplasm, n=3) were retrospectively reviewed by 2 patholo gists. The selection of study candidates was built on the histo logical features described by recent literature 1, 35 and sufficient amount of tissue available to construct a tissue microarray (TMA). The criteria for selection among the above tumors included the presence of glandular formation or secretory activity. The final specimens comprised 30 cases initially diagnosed as AciCC (n=16), ANOS (n=6), MEC (n=3), CAC (n=2), salivary duct carcinoma (SDC; n=1), squamous cell carcinoma (n= 1), and oncocytic carcinoma (n=1). Additionally, 6 conventional AciCC cases, morphologically showing unequivocal serous acinar dif ferentiation, and 2 SDC cases were selected for reference. For all 38 cases, TMAs were generated using a manual tissue arrayer (Pathology Devices, Westminster, MD, USA). Two 1.0 or 1.5 mm cores were taken from donor blocks and arrayed into recip ient blocks. Clinical data were obtained through review of me dical records and pathologic staging was based on the Cancer Staging Manual of American Joint Committee. 8 Diseasefree survival was assessed from the time of histological diagnosis to recurrence or death, based on review of the patients' medical re cords and information from the National Health Insurance. A ttest was employed to characterize the relationships between quantitative variables and the Fisher's exact test was used to characterize the relationship between categorical variables. Dis easefree survival periods with 95% confidence intervals (CI) were estimated using the KaplanMeier method, with statisti cal significance of differences between groups estimated by log rank test. A pvalue of <0.05 was defined as statistically signif icant. Statistical analysis was performed using SPSS ver. 18 (SPSS Inc., Chicago, IL, USA).
Immunohistochemistry and ETV6 FISH
From TMA blocks, 4μm sectioned slides were obtained and prepared for immunohistochemistry and FISH. Immunohisto chemical stainings were performed using the Ventana auto stainer and ultra view DAB detection kit (Ventana, Tucson, AZ, USA) according to manufacturer's instructions. The anti body sources and dilutions are listed in Table 1 . FISH was per formed using a breakapart probe for the ETV6 gene (Abbott Molecular, Des Plaines, IL, USA) according to the manufactur er's recommendations. FISH slides were examined with an Olym pus BX51 fluorescence microscope (Olympus, Tokyo, Japan) us ing a 100× objective. Through FITC and Texas Red Band pass filters, each image was obtained with an Olympus DP70 cam era using DP Controller (ver. 3.3.1.292) acquisition software. Fifty to 100 cells were examined in each case. A single green (or red) signal without a corresponding red (or green) signal in ad dition to a fused signal was considered negative (nonrearrang ed) in the present study. Red and green signals that were less than 2 signal diameters apart were considered as a single fused signal. The average percentage of split signal in 6 referential AciCCs, showing unequivocal serous acinar differentiation (con ventional AciCC) was 4.565 and standard deviation (SD) 3.042. Thus, we considered cases, if more than 15% (mean+3 SD, rounded up) of examined nuclei showed a split signal, as posi tive for translocation which is the similar cutoff value used in previous literature. 1 The slides were independently interpreted by 2 observers. If 1020% of the analyzed cells showed a split signal, more cells were enumerated and the first and second cell count readings by the 2 observers were added together and a percentage was calculated. Valid FISH results were obtained in 31 out of 38 cases. The laboratory used breast secretory carcino ma as a positive control. 
RESULTS

Verifying MASC with ETV6 translocation and its clinicopathologic characteristics
Among the 31 technically successful cases, 13 cases showed ETV6 translocation, reclassified as MASC, and 10 cases showed intact ETV6, categorized as mimic MASC (Fig. 1) . The other 8 cases served as a reference, including 6 conventional AciCCs and 2 SDCs, and showed intact ETV6. On average, 57.65% of examined cells showed a split signal with ETV6 translocation (MASC) in 13 cases, while 9.55% of examined cells showed a split signal in 10 cases with intact ETV6 (mimic MASC). The percentage of cells with a split signal ranged between 20.75% and 78.57% in cases with ETV6 translocation, and between 3.10% and 12.96% in cases with intact ETV6.
The clinicopathologic features of 23 MASC candidates with ETV6 translocation (MASC, n=13) or with intact ETV6 (mimic MASC, n=10), are summarized in Table 2 . For referential com parison, conventional AciCCs (n=15) surgically treated in our institution are also summarized in Table 2 .
The 13 MASC cases consisted of 8 males and 5 females. Al though no differences in gender distribution were found be tween MASC and mimic MASC cases, a noticeable male predi lection was observed compared with conventional AciCCs, which affected females more frequently than males (F:M=12:3). The average age in the MASCs, mimic MASCs, and conventional Histologically, the most frequent features in the 13 MASC cases were well circumscribed, encapsulated, or multinodular masses, showing papillarycystic, microcystic, solid, follicular or their combination growth pattern. Cytomorphologically, most tumors showed an admixture of variable cell types. Some cells were smaller than typical acinar cells appearing to have an in creased nuclear to cytoplasmic ratio, and showed eosinophilic or finely granular cytoplasm and ovoid basophilic nuclei, known as intercalated ductlike cells. Other cells showed a more abun dant or vacuolated cytoplasm and lowgrade wrinkled nuclei. A small number of cells appeared clear or mucincontaining. Nu merous variablesized spaces were frequently observed and the spaces were usually clear but sometimes contained pinkish to grayish bluecolored amorphous materials, which were positive for periodic acidSchiff. As stated in previous literature, the abovementioned characteristics were predominant features of MASC and corresponded to microcystic, papillarycystic, or fol licular type of AciCC. 15 These usual morphological MASC fea tures are illustrated in Fig. 2 .
However, 3 MASC cases showed unusual histological features. One case was macrocystic, measuring up to 2.5 cm, and partial ly filled with intraluminal papillary proliferation. A macrocys tic tumor with sparse projection could be misidentified as CAC. Nevertheless, epithelial configuration of the cyst lining and papillary projection was similar to the mentioned MASC. An other case showed large but variablesized cysts interspersed among the fibrous stroma. The tumor showed focal prolifera tion of the epithelial lining and even cribriform appearance in some relatively small islands. These features were also reminis cent of CAC, however, epithelial lining cells were similar to MASC rather than the cuboidal, clear, tall columnar, or onco cytic features of CAC. Notably, the thin epithelial lining cells often exhibited mucinous cytoplasm (Fig. 3) .
The third case showed a distinct morphologic change previ ously referred to as dedifferentiation or highgrade transforma tion of AciCC. 9 The tumor was composed of 2 distinct areas with an obvious transformation zone. Histological features of one area corresponded to microcystic and papillarycystic MASC and the other area showed poor zymogen granule containing (Fig. 4) . A diversity of morphological features with intact ETV6 was also obtained. Among 10 mimic MASCs, 3 cases could be in terpreted as CAC. Though the cytomorphologic features were not uniform, the tumor cells were slightly different from MASC, showing cuboidal, tall columnar, clear to oncocytic features. Additionally, the epithelial lining of cysts was more evenly thin in CAC than MASC. Additionally, when papillary projections were present, they were mostly large papillae covered with co lumnar or tall cuboidal cells. Others showed nonspecific mor phologies, corresponding to ANOS. Infiltrating nests of clear cells, glandular growth in the prominent sclerosing background, or solid nests surrounded by very thin fibrovascular septa with reticular and abundant cytoplasm were other examples of mim ic MASC. These architectural patterns were obviously different from MASC, but cytomorphological features were similar. Two cases of MECs lacking mucous and epidermoid cells were ini tially similar to MASC, but careful examination can help in dis tinguishing MEC from MASC. Simultaneously, oncocytoma lacking characteristic cytoplasm features could also mimic MA SC. The above morphological features mimicking MASC are il lustrated in Fig. 5 .
Immunohistochemical findings
Immunohistochemically, all 13 MASC cases were positive for S100 protein. Most staining patterns were strong and diffuse, except for a case showing dedifferentiation (Fig. 6 ). Three out of 10 mimic MASCs expressed S100 protein and no expression was observed in 6 conventional AciCCs. Gross cystic disease fluid protein 15 (GCDFP15) immunostains were focally posi tive for 2 out of 13 MASCs, 3 out of 10 mimic MASCs, and none of the conventional AciCCs. DOG1 was expressed in 3 conventional AciCCs and 1 MASC, with weak apical or apico luminal membranous staining. Estrogen receptor (ER) and pro gesterone receptor (PR) were all negative for MASC, mimic MASC and conventional AciCCs (Table 3) .
DISCUSSION
In this study we investigated the new salivary gland tumor, known as MASC, to clarify the clinical, histological, and im munohistochemical characteristics, and to determine any pathog nomonic features helpful in diagnosing MASCs.
The first MASC report focused on features reminiscent of breast secretory carcinoma. 1 In recent years, there have been several studies extending the clinical, histological, and immu nohistochemical properties of MASCs. 3, 5 However, MASC clini copathologic features appear to be indistinctive and the molecu lar demonstration of ETV6 rearrangement is the only diagnos tic method. Regardless of the originality of this entity, a salivary gland tumor with ETV6 translocation has yet to be document ed in Korea.
The present study compared MASC candidate groups with an intact ETV6 and ETV6 translocation. To evaluate MASCs with an emphasis on easy identification of specific characteris tics, consideration of the ideal cutoff value to assess the ETV6 FISH results was necessary. In this study, a 15% cutoff value was determined as acceptable. The negative control cutoff val ue (mean+3 SD, 13.688) showed a 99.7% CI for intact ETV6. The cutoff value used (15%) was slightly higher than the neg ative control cutoff value. Moreover, the interpretation of a sin gle colored signal without a corresponding colored signal in ad dition to a fused signal as negative could decrease the percent age of positive cells for ETV6 translocation. The highest nega tive value for ETV6 translocation was 12.96% and the lowest positive value was 20.75%. This result shows the importance of determining an accurate cutoff value in a study.
Most MASC features overlapped with subtypes of AciCC. Overall, papillarycystic, microcystic, or their mixture types were predominantly observed. AciCCs, according to the current World Health Organization classification, are comprised of het erogeneous tumors. Many cell types, including acinar, interca lated duct type, vacuolated, clear, and nonspecific glandular cells, and variable growth patterns such as solid, microcystic, papillarycystic, and follicular, are described as constituents of AciCC. ANOS is also a heterogeneous tumor group, and their diagnosis is based on the lack of features that characterize other salivary gland adenocarcinomas. According to prior studies and our results, a considerable number of ANOS and zymogen gra nulepoor AciCCs belong to the MASC group. The concept that MASC is a distinctive entity of salivary gland tumors re quires more consideration, however, no zymogen granulerich AciCC or SDC has shown an ETV6 rearrangement. Our study revealed previously undescribed histology in ETV6rearranged tumors, such as a solid pattern resembling dedifferentiated Aci CC and a large cyst with sparse papillary proliferation. Chiosea et al. 4 reported that the results of ETV6 FISH in 4 cases of AciCC with highgrade malformation were all negative for ETV6 trans location. Our results were contrary to the previous result, even in one case.
Apart for a few exceptions, the histological outline of MASC appears evident, and mimic MASC cases without an ETV6 translocation could be differentiated from MASC by careful his tological examination. However, MASC diagnosis in routine practice remains difficult by histological examination only. We attempted to identify an immunohistochemical marker for MASC. DOG1, known as a novel marker of salivary acinar and intercalated duct differentiation, was not helpful. 10 GCDFP15, ER, and PR were considered a possibility due to their mamma rylike character, but were not expressed in MASC. The S100 protein was highly sensitive, but showed low specificity to dif ferentiate MASC from mimic MASC. Thus, new immunohis tochemical markers that could substitute ETV6 FISH are re quired.
In conclusion, MASC could be a molecularly welldefined salivary gland neoplasm, encompassing some portions of AciCC and ANOS, but its histological spectrum and clinical implica tion need further investigation.
